NEW YORK -- (Business Wire)

The Law Office of Abe Shainberg is investigating the Board of Directors of Inspire Pharmaceuticals, Inc. (Nasdaq: ISPH) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Merck (NYSE: MRK). Under the terms of the proposed transaction, Inspire shareholders will receive $5.00 in cash per share for a total transaction value of approximately $430 million.

The investigation concerns whether the Inspire Board of Directors breached their fiduciary duties to Inspire stockholders by failing to adequately shop the Company before entering into this transaction and whether Merck is underpaying for Inspire shares. According to Yahoo! Finance, at least one analyst set a price target of $10.00 for Inspire stock.

If you own common stock in Inspire and wish to obtain additional information, please contact Abe Shainberg, Esq. either via email at as@ashainberglaw.com or by telephone at (212) 425-7286, or visit http://www.ashainberglaw.com/inspire-pharmaceuticals-inc.html.

Mr. Shainberg has expertise in prosecuting investor securities litigation, is a certified and registered arbitrator and mediator involving financial matters, and represents investors in various matters nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:

Law Office of Abe Shainberg
Abe Shainberg, Esq., 212-425-7286
Fax: 866-699-3880
as@ashainberglaw.com

Source: Law Office of Abe Shainberg